跳至主要内容
临床试验/NCT04325386
NCT04325386已完成不适用

Clozapine CHAMPION-ECHO (Center for Help and Assistance for Maryland Prescribers- Improving Outcomes Network Using Extension for Community Healthcare Outcomes); Randomized Educational Study to Improve Clozapine Prescribing Through a Project ECHO Model

University of Maryland, Baltimore2 个研究点 分布在 1 个国家目标入组 266 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
266
试验地点
2
主要终点
Change in Clozapine Prescriptions Using Medicaid Claims Data

研究概览

简要总结

In a randomized controlled design with approximately 26 biweekly sessions over 12 months, the investigators propose to test the effectiveness of an ECHO-based intervention for improving the use of clozapine in people eligible for clozapine. The sessions will include: 1) active dissemination of knowledge and information by an expert "hub" followed by 2) clozapine case presentations and vignettes submitted by the "spokes".

This intervention, Clozapine CHAMPION-ECHO (Center for Help and Assistance for Maryland Prescribers- Improving Outcomes Network using Extension for Community Healthcare Outcomes, will be referred to as "CHAMPION" throughout.. To minimize ANC monitoring barriers and maximize recruitment, the investigators will provide Food and Drug Administration (FDA)-cleared ANC point of care (POC) monitoring devices to all study sites, including those in the control condition. The investigators will enroll at least 300 prescribers and additional clinical team members (up to 300) from up to 60 mental health clinics (MHCs) and other treatment sites; approximately half the participants will be randomized to CHAMPION and half randomized to enhanced treatment as usual (ETAU).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
22 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Located at a site in the State of Maryland with at least 3 prescribers at the site.
  • Prescribers/clinical team should be licensed in the State of Maryland and have prescribed antipsychotics previously.
  • Between the ages of 22 and 85 years old
  • Willing to participate in pre- and post-testing
  • Willing to agree to try to participate in the CHAMPION sessions

排除标准

  • Not willing to participate in CHAMPION Sessions

结局指标

主要结局

Change in Clozapine Prescriptions Using Medicaid Claims Data

时间窗: Baseline and endpoint changes after 12 month intervention

The data outcome is new clozapine prescriptions by provider based on a variable linking provider ID to percent of clozapine prescriptions.

Change in Prescriber Knowledge of Clozapine Use

时间窗: Baseline and endpoint changes after 12 month intervention

A 52 item Multiple Choice Questionnaire will be used to assess knowledge. The knowledge-based test questions will consist of 2 questions per 26 topic areas and will conform to best practices and guidelines for design of the questions. The total mean score will range from 0-52 with higher scores being better outcome. The questions were developed and validated by the team.

Change in Self-reported Competence for Clozapine Use

时间窗: Baseline and endpoint changes after 12 month intervention

We will use a mean score on a Visual Analog Scale (VAS) (0-100 mm) for overall competence with higher scores being better outcome.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Deanna Kelly

Cheif Treatment Research Program

University of Maryland, Baltimore

研究点 (2)

Loading locations...

相似试验